Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2

Status

Completed 32Terminated 9Active not recruiting 9Unknown 3Withdrawn 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 2Gynecologic 1Genitourinary 1

Conditions

Sarcoma, Alveolar Soft Part 1Sarcoma 1Neoplasms 1Endometrial Neoplasms 1Carcinosarcoma 1Carcinoma, Renal Cell 1

Interventions

Cisplatin 267Oxaliplatin 194Carboplatin 189Capecitabine 183Docetaxel 176apatinib 164Paclitaxel 158Bevacizumab 155Gemcitabine 154Radiotherapy 146camrelizumab 145Fluorouracil 144Cyclophosphamide 123Irinotecan 119Drug Therapy 118sintilimab 107Etoposide 99anlotinib 90S 1 (combination) 88Leucovorin 85pembrolizumab 82Pemetrexed 78Doxorubicin 77toripalimab 76tislelizumab 75Dexamethasone 70Trastuzumab 65Neoadjuvant Therapy 64Rituximab 62Cetuximab 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Unknown × cediranib × Clear all
NCT03741426 2023-06-07

WIRE

Cambridge University Hospitals NHS Foundation Trust

Phase 2 Unknown
60 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT03570437 2022-03-02

COPELIA

University of Manchester

Phase 2 Unknown
124 enrolled
GynecologicSarcoma

Carcinosarcoma, Neoplasms, Endometrial Neoplasms

NCT01337401 2019-01-24

CASPS

Institute of Cancer Research, United Kingdom

Phase 2 Unknown
36 enrolled
Sarcoma

Sarcoma, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon âš¡